F. Rathgeb

760 total citations
9 papers, 421 citations indexed

About

F. Rathgeb is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, F. Rathgeb has authored 9 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in F. Rathgeb's work include Drug Transport and Resistance Mechanisms (3 papers), Cancer therapeutics and mechanisms (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). F. Rathgeb is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Cancer therapeutics and mechanisms (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). F. Rathgeb collaborates with scholars based in Germany, Hungary and United States. F. Rathgeb's co-authors include Roger G. Spragg, Werner Seeger, Jay A. Johannigman, James F. Lewis, Friedemann Taut, Guy A. Richards, Geoff Bellingan, Dietrich Häfner, Gerd Rippin and Pierre‐François Laterre and has published in prestigious journals such as New England Journal of Medicine, European Respiratory Journal and Lung Cancer.

In The Last Decade

F. Rathgeb

9 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Rathgeb Germany	6	351	99	64	63	54	9	421
A. Sautegeau France	8	576 1.6×	91 0.9×	40 0.6×	35 0.6×	14 0.3×	20	655
Gabriele Stöhr	2	263 0.7×	31 0.3×	102 1.6×	41 0.7×	34 0.6×	3	330
Carl-Johan Wickerts Sweden	6	91 0.3×	30 0.3×	17 0.3×	116 1.8×	23 0.4×	9	314
Joel Mermis United States	8	192 0.5×	139 1.4×	17 0.3×	55 0.9×	23 0.4×	18	322
Özlem Ural Gürkan Türkiye	7	126 0.4×	16 0.2×	11 0.2×	64 1.0×	29 0.5×	12	318
Kevin Davidson United States	7	119 0.3×	102 1.0×	17 0.3×	33 0.5×	37 0.7×	12	270
T. Minor Germany	7	108 0.3×	17 0.2×	14 0.2×	51 0.8×	44 0.8×	13	336
Andrew F. Cumpstey United Kingdom	9	80 0.2×	34 0.3×	21 0.3×	32 0.5×	35 0.6×	19	251
Martin Clark United Kingdom	5	430 1.2×	99 1.0×	39 0.6×	75 1.2×	7 0.1×	8	617
Mitchell L. Rhodes United States	10	213 0.6×	22 0.2×	26 0.4×	21 0.3×	25 0.5×	20	345

Countries citing papers authored by F. Rathgeb

Since Specialization

Citations

This map shows the geographic impact of F. Rathgeb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Rathgeb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Rathgeb more than expected).

Fields of papers citing papers by F. Rathgeb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Rathgeb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Rathgeb. The network helps show where F. Rathgeb may publish in the future.

Co-authorship network of co-authors of F. Rathgeb

This figure shows the co-authorship network connecting the top 25 collaborators of F. Rathgeb. A scholar is included among the top collaborators of F. Rathgeb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Rathgeb. F. Rathgeb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Spragg, Roger G., James F. Lewis, Hans‐Dieter Walmrath, et al.. (2004). Effect of Recombinant Surfactant Protein C–Based Surfactant on the Acute Respiratory Distress Syndrome. New England Journal of Medicine. 351(9). 884–892. 273 indexed citations

2.

Spragg, Roger G., Jaime D. Lewis, Werner Seeger, W Wurst, & F. Rathgeb. (1999). TREATMENT OF ARDS WITH rSP-C SURFACTANT.. Shock. 12(Supplement). 7–8. 8 indexed citations

3.

Ukena, D., Ulf Harnest, Raimundas Sakalauskas, et al.. (1998). [Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma].. PubMed. 52(7). 377–84. 3 indexed citations

4.

Steinijans, V W, Markus Neuhäuser, Thomas Hummel, et al.. (1998). Asthma management: the challenge of equivalence.. PubMed. 36(3). 117–25. 9 indexed citations

5.

Ukena, D., Ulf Harnest, Raimundas Sakalauskas, et al.. (1997). Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma. European Respiratory Journal. 10(12). 2754–2760. 109 indexed citations

6.

Kriegmair, M., et al.. (1997). Phase I and pharmacokinetic study of the P-glycoprotein modulator dexniguldipine-HCL.. PubMed. 2(2). 55–61. 10 indexed citations

7.

Ukena, D., et al.. (1995). Tolerance, safety, and kinetics of the new antineoplastic compound dexniguldipine-HCl after oral administration: a phase I dose-escalation trial. Cancer Chemotherapy and Pharmacology. 36(2). 160–164. 5 indexed citations

8.

Goedhals, L., et al.. (1995). Bioavailability and pharmacokinetic characteristics of dexniguldipine-HCl, a new anticancer drug.. PubMed. 33(12). 664–9. 3 indexed citations

9.

Schroeder, M., et al.. (1991). Application of the dihydropyridine derivate B8509-035 in resistent Small Cell Lung Cancer (SCLC). Lung Cancer. 7. 140–140. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact